Lilly to participate in TD Cowen's 45th Annual Health Care Conference
Eli Lilly (NYSE: LLY) has announced its participation in TD Cowen's 45th Annual Health Care Conference scheduled for March 4, 2025. Jake Van Naarden, executive vice president and president of Lilly Oncology, will participate in a fireside chat at 1:50 p.m. Eastern time.
The event will be accessible through a live audio webcast on Lilly's investor website under the 'Webcasts & Presentations' section. Investors and interested parties can access the replay of the presentation on the same platform for approximately 90 days following the event.
Eli Lilly (NYSE: LLY) ha annunciato la sua partecipazione alla 45ª Conferenza Annuale sulla Salute di TD Cowen, programmata per il 4 marzo 2025. Jake Van Naarden, vicepresidente esecutivo e presidente di Lilly Oncology, parteciperà a una chiacchierata informale alle 13:50 ora orientale.
L'evento sarà accessibile tramite un webcast audio in diretta sul sito web per investitori di Lilly, nella sezione 'Webcast e Presentazioni'. Gli investitori e le parti interessate potranno accedere alla registrazione della presentazione sulla stessa piattaforma per circa 90 giorni dopo l'evento.
Eli Lilly (NYSE: LLY) ha anunciado su participación en la 45ª Conferencia Anual de Salud de TD Cowen, programada para el 4 de marzo de 2025. Jake Van Naarden, vicepresidente ejecutivo y presidente de Lilly Oncology, participará en una charla informal a la 1:50 p.m. hora del Este.
El evento será accesible a través de un webcast de audio en vivo en el sitio web de inversores de Lilly, en la sección 'Webcasts y Presentaciones'. Los inversores y partes interesadas podrán acceder a la repetición de la presentación en la misma plataforma durante aproximadamente 90 días después del evento.
엘리 릴리 (NYSE: LLY)가 TD Cowen 제45회 연례 헬스케어 컨퍼런스에 참여한다고 발표했습니다. 이 행사는 2025년 3월 4일에 예정되어 있습니다. 제이크 반 나르덴, 엘리 릴리 온콜로지의 부사장 겸 사장이 동부 표준시 기준 오후 1시 50분에 파이어사이드 채팅에 참여할 예정입니다.
이 이벤트는 릴리의 투자자 웹사이트의 '웹캐스트 및 발표' 섹션을 통해 실시간 오디오 웹캐스트로 접속할 수 있습니다. 투자자와 이해 관계자는 이벤트 후 약 90일 동안 동일한 플랫폼에서 발표 녹음을 접근할 수 있습니다.
Eli Lilly (NYSE: LLY) a annoncé sa participation à la 45e Conférence Annuelle sur la Santé de TD Cowen, prévue pour le 4 mars 2025. Jake Van Naarden, vice-président exécutif et président de Lilly Oncology, participera à une discussion informelle à 13h50, heure de l'Est.
L'événement sera accessible via un webcast audio en direct sur le site des investisseurs de Lilly, dans la section 'Webcasts et Présentations'. Les investisseurs et les parties intéressées pourront accéder à l'enregistrement de la présentation sur la même plateforme pendant environ 90 jours après l'événement.
Eli Lilly (NYSE: LLY) hat seine Teilnahme an der 45. jährlichen Gesundheitskonferenz von TD Cowen angekündigt, die für den 4. März 2025 geplant ist. Jake Van Naarden, Executive Vice President und Präsident von Lilly Oncology, wird um 13:50 Uhr Eastern Time an einem Fireside-Chat teilnehmen.
Die Veranstaltung wird über einen Live-Audio-Webcast auf der Investorenwebsite von Lilly in der Rubrik 'Webcasts & Präsentationen' zugänglich sein. Investoren und interessierte Parteien können die Wiederholung der Präsentation auf derselben Plattform für etwa 90 Tage nach der Veranstaltung abrufen.
- None.
- None.
A live audio webcast will be available on the "Webcasts & Presentations" section of Lilly's investor website at https://investor.lilly.com/webcasts-and-presentations. A replay of the presentation will be available on this same website for approximately 90 days.
About Lilly
Lilly is a medicine company turning science into healing to make life better for people around the world. We've been pioneering life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges: redefining diabetes care; treating obesity and curtailing its most devastating long-term effects; advancing the fight against Alzheimer's disease; providing solutions to some of the most debilitating immune system disorders; and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we're motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more, visit Lilly.com and Lilly.com/news, or follow us on Facebook, Instagram, and LinkedIn. F-LLY
Trademarks and Trade Names
All trademarks or trade names referred to in this press release are the property of the company, or, to the extent trademarks or trade names belonging to other companies are references in this press release, the property of their respective owners. Solely for convenience, the trademarks and trade names in this press release are referred to without the ® and ™ symbols, but such references should not be construed as any indicator that the company or, to the extent applicable, their respective owners will not assert, to the fullest extent under applicable law, the company's or their rights thereto. We do not intend the use or display of other companies' trademarks and trade names to imply a relationship with, or endorsement or sponsorship of us by, any other companies.
Refer to: | Ashley Hennessey; gentry_ashley_jo@lilly.com; 317-416-4363 (Media) |
Michael Czapar; czapar_michael_c@lilly.com; 317-617-0983 (Investors) |
View original content to download multimedia:https://www.prnewswire.com/news-releases/lilly-to-participate-in-td-cowens-45th-annual-health-care-conference-302378432.html
SOURCE Eli Lilly and Company
FAQ
When is Eli Lilly (LLY) presenting at TD Cowen's Health Care Conference 2025?
Who will represent LLY at the TD Cowen Healthcare Conference 2025?
How can investors watch LLY's presentation at the TD Cowen Conference?
How long will LLY's TD Cowen Conference presentation be available for replay?
